BofA warns Fed risks policy mistake with early rate cuts
Procaps Group, S.A. (NASDAQ:PROC) announced Monday that its board of directors appointed Fernando Moreira Muniz and Carlos Romero-Camacho as new directors, effective the same day. The appointments fill vacancies created by the resignations of Jose Frugone Domke and Jorddy Antonio Pérez Galindo, with the new directors serving until the next annual general meeting of shareholders that approves the annual accounts.
According to a press release statement and SEC filing, Mr. Moreira Muniz was also named a member of the Audit Committee, while Mr. Romero-Camacho will serve on both the Compensation and Nominating Committees. The board determined that both appointees meet the Nasdaq Stock Market’s definition of independent director, and that Mr. Moreira Muniz satisfies the Securities and Exchange Commission’s heightened independence requirements for audit committee service.
Mr. Moreira Muniz is currently Director and CEO of Urufarma, a pharmaceutical manufacturing company operating in Eastern Europe and Latin America, a role he has held since 2007. He also serves as Secretary for the Association of National Laboratories in Uruguay and previously held a management position at Banco Santander (BME:SAN) in Uruguay. He holds an MBA from the University of Montevideo and a bachelor’s degree in international business from the Catholic University of Uruguay.
Mr. Romero-Camacho is Chief People & Corporate Affairs Officer at Insud Pharma Group, a global pharmaceutical group, a position he has held since 2011. He has experience in senior human resources and legal roles at companies including Renault (EPA:RENA) Trucks, Bristol-Myers Squibb (NYSE:BMY), and SmithKline Beecham, and has served as a representative in public and private institutions. Mr. Romero-Camacho holds a law degree from UAM, an MBA from ICADE, and completed the General Management Program at INSEAD.
The company reported that since the beginning of its last fiscal year, there have been no transactions involving Mr. Moreira Muniz or Mr. Romero-Camacho in which the amount exceeded $120,000.
This information is based on a press release statement and details disclosed in a recent SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.